EMH Schweizerischer Ärzteverlag AG
Farnsburgerstrasse 8
CH-4132 Muttenz
+41 (0)61 467 85 44
support@swisshealthweb.ch
www.swisshealthweb.ch
Published on 20.06.2019
Evidence for the effectiveness of exercise to improve physical functioning, body composition, fatigue and quality of life in cancer patients is promising and, in general, exercise is safe and feasible throughout the course of cancer care.
Breast | Prostate | Lung | Colorectal | |
---|---|---|---|---|
Physical activity | ▼ | ▼▼ (colon) | ||
Unhealthy diet | ▲ | ▲▲ | ||
Obesity | ▲▲ | ▲ (w) ▲▲▲(m) | ||
Diabetes | ▲▲ | ▲▲ | ||
Hypertension | ▲ | ▲ | ||
Tobacco smoking | ▲ | ▲▲ | ▲▲▲ |
Breast | Prostate | Lung | Colorectal | |
---|---|---|---|---|
Exercise during cancer treatment | ||||
Physical function | ●● | ● | ● | ● |
Fatigue | ●● | ●/●● | ●● | ●● |
Quality of life | ● | ● | ● | ● |
Exercise after cancer treatment | ||||
Physical function | ●/●● | ●● | ●● | ●● |
Body composition | ● | ● | ● | ● |
Fatigue | ●/●● | ●● | ●● | ●● |
Quality of life | ● | ● | ● | ● |
Cancer recurrence | ● | ● | ● | |
Survival | ● | ● | ● | ● |
Exercise during palliative care | ||||
Physical function | ● | ● | ● | ● |
Body composition | ● | ● | ● | ● |
Fatigue | ● | ● | ● | ● |
Quality of life | ● | ● | ● | ● |
Relative contraindications | Recent weight gain (>2 kg during the 3 days preceding exercise) |
Decrease in systolic blood pressure during exercise | |
New York Heart Association class IV cardiac status | |
Ventricular arrhythmia at rest or during exercise | |
Supine heart rate ≥100 beats/min | |
Neurological toxicity >grade 2 | |
Asymptomatic central neurological lesions | |
Asymptomatic bone metastases | |
Absolute contraindications | Progressive increase in dyspnoea at rest or during exercise for the 3–5 days preceding exercise |
Uncontrolled diabetes mellitus | |
Acute disease or fever | |
Recent embolism | |
Thrombophlebitis | |
Myocarditis or active pericarditis | |
Symptomatic central neurological lesions | |
Haematological toxicity: platelets <50 000/mm3, leucocytes <1500/mm3, haemoglobin <8 g/dl | |
Symptomatic central neurological lesions | |
Osteolytic or painful bone metastases |
Published under the copyright license.
"Attribution - Non-Commercial - NoDerivatives 4.0"
No commercial reuse without permission.
See: emh.ch/en/emh/rights-and-licences/